Log in

NYSEAMERICAN:INTTinTEST Stock Price, Forecast & News

$4.70
+0.30 (+6.82 %)
(As of 08/7/2020 04:00 PM ET)
Add
Compare
Today's Range
$4.47
Now: $4.70
$5.00
50-Day Range N/A
52-Week Range
$2.08
Now: $4.70
$6.20
Volume48,152 shs
Average Volume25,329 shs
Market Capitalization$49.04 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
inTEST Corporation designs, manufactures, and markets thermal management products and semiconductor automated test equipment interface solutions worldwide. The company operates in two segments, Thermal Products (Thermal) and Electromechanical Semiconductor Products (EMS). The Thermal segment offers ThermoStream temperature management tools, MobileTemp systems, ThermoChambers, Thermal Platforms, ThermoChuck precision vacuum platform assemblies, Thermonics temperature conditioning products, and EKOHEAT and EASYHEAT induction heating systems. Its products are used to test semiconductor wafers and ICs, electronic components and assemblies, mechanical assemblies, and electromechanical assemblies. The EMS segment provides in2 and Cobal Series manipulators that hold various test heads and enable an operator to reposition a test head for alternate use with various probers or handlers on a test floor; and docking hardware products that protect the interface contacts and ensure repeatable and precise alignment between the test head's interface board and the prober's probing assembly or the handler's test socket. This segment also offers tester interfaces that provide electrical connections between the tester and the wafer prober or IC handler to carry the electrical signals between the tester and the probe card on the prober or the test socket on the handler. Its products are used in production testing of wafers and specialized packaged ICs in back-end testing by semiconductor manufacturers. The company markets and sells its products directly, as well as through ATE manufacturers, independent sales representatives, and distributors to semiconductor manufacturers, semiconductor test subcontractors, third-party foundries, test and assembly houses, and original equipment manufacturers. inTEST Corporation was founded in 1981 and is headquartered in Mount Laurel, New Jersey.
Read More
inTEST logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.16 out of 5 stars


Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Semiconductors
Sub-IndustryN/A
Current SymbolNYSEAMERICAN:INTT
Previous SymbolNYSEMKT:INTT
CUSIPN/A
Phone+1-856-5058800

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees209
Market Cap$49.04 million
Next Earnings Date11/13/2020 (Estimated)
OptionableNot Optionable
$4.70
+0.30 (+6.82 %)
(As of 08/7/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive INTT News and Ratings via Email

Sign-up to receive the latest news and ratings for INTT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











inTEST (NYSEAMERICAN:INTT) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of inTEST?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for inTEST in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for inTEST
.

When is inTEST's next earnings date?

inTEST is scheduled to release its next quarterly earnings announcement on Friday, November 13th 2020.
View our earnings forecast for inTEST
.

How were inTEST's earnings last quarter?

inTEST Co. (NYSEAMERICAN:INTT) announced its quarterly earnings results on Thursday, August, 6th. The semiconductor company reported $0.05 EPS for the quarter, beating the Zacks' consensus estimate of ($0.01) by $0.06.
View inTEST's earnings history
.

What guidance has inTEST issued on next quarter's earnings?

inTEST updated its third quarter 2020 After-Hours earnings guidance on Thursday, August, 6th. The company provided earnings per share guidance of 0.04-0.09 for the period, compared to the Thomson Reuters consensus estimate of $0.03. The company issued revenue guidance of $13.5-14.5 million, compared to the consensus revenue estimate of $13.29 million.

What price target have analysts set for INTT?

1 equities research analysts have issued 12-month price targets for inTEST's stock. Their forecasts range from $6.00 to $6.00. On average, they expect inTEST's share price to reach $6.00 in the next year. This suggests a possible upside of 27.7% from the stock's current price.
View analysts' price targets for inTEST
.

Has inTEST been receiving favorable news coverage?

News stories about INTT stock have trended very positive on Saturday, InfoTrie Sentiment reports. InfoTrie identifies negative and positive press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. inTEST earned a news sentiment score of 4.0 on InfoTrie's scale. They also gave media coverage about the semiconductor company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near future.
View the latest news about inTEST
.

Are investors shorting inTEST?

inTEST saw a drop in short interest in July. As of July 15th, there was short interest totaling 19,100 shares, a drop of 49.1% from the June 30th total of 37,500 shares. Based on an average daily trading volume, of 34,000 shares, the short-interest ratio is currently 0.6 days. Approximately 0.2% of the shares of the stock are short sold.
View inTEST's Current Options Chain
.

Who are some of inTEST's key competitors?

What other stocks do shareholders of inTEST own?

Based on aggregate information from My MarketBeat watchlists, some companies that other inTEST investors own include Baozun (BZUN), Applied Materials (AMAT), Gilead Sciences (GILD), Pfizer (PFE), AbbVie (ABBV), IBM (IBM), Johnson & Johnson (JNJ), Lam Research (LRCX), Nektar Therapeutics (NKTR) and Ring Energy (REI).

Who are inTEST's key executives?

inTEST's management team includes the following people:
  • Mr. James Pelrin, Pres, CEO & Director (Age 67)
  • Mr. Hugh T. Regan Jr., Treasurer, CFO & Sec. (Age 59)

What is inTEST's stock symbol?

inTEST trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "INTT."

Who are inTEST's major shareholders?

inTEST's stock is owned by a number of retail and institutional investors. Top institutional investors include LSV Asset Management (0.99%) and GWM Advisors LLC (0.10%). Company insiders that own inTEST stock include James Pelrin, Robert E Matthiessen and William Kraut.
View institutional ownership trends for inTEST
.

Which institutional investors are selling inTEST stock?

INTT stock was sold by a variety of institutional investors in the last quarter, including LSV Asset Management.
View insider buying and selling activity for inTEST
.

Which institutional investors are buying inTEST stock?

INTT stock was purchased by a variety of institutional investors in the last quarter, including GWM Advisors LLC.
View insider buying and selling activity for inTEST
.

How do I buy shares of inTEST?

Shares of INTT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is inTEST's stock price today?

One share of INTT stock can currently be purchased for approximately $4.70.

How big of a company is inTEST?

inTEST has a market capitalization of $49.04 million. inTEST employs 209 workers across the globe.

What is inTEST's official website?

The official website for inTEST is www.intest.com.

How can I contact inTEST?

inTEST's mailing address is 804 E Gate Dr Ste 200, MOUNT LAUREL, NJ 08054-1209, United States. The semiconductor company can be reached via phone at +1-856-5058800.

This page was last updated on 8/8/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.